CompletedPhase 4

A Single Center Trial of Donor Site Wound Dressings After Split Thickness Skin Grafting.

Pakistan90 participantsStarted 2022-08-01

Plain-language summary

The goal of this clinical trial\] is to compare different types of dressings used and there outcomes on STSG donor site wound. The main question\[s\] it aims to answer are: * the effectiveness of different donor site dressings and their adverse outcomes * the satisfaction of patients with the donor site dressing will be observed. Participants will randomly allocated different types of dressings for split thickness skin graft donor site wound which include alginate hydrocolloid hydrofiber silicon film guaze

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * . Patients of aged 18 years and above of either gender underwent single donor-site wounds after split-skin grafting and surface area larger than 10 cm2 were included in the study Exclusion Criteria: * Patients on chemotherapy or corticosteroids were excluded from the study. Non-probability consecutive sampling was employed

What they're measuring

to asses the effective of dressings by measuring itching , pain and scarring

Timeframe: six month

Trial details

NCT IDNCT06044519

SponsorDow University of Health Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02-28

View on ClinicalTrials.gov More Donor Site Complication trials